GL1X · GenesisL1 explorer

MolNFT v1 · #126711 · protein

Cocktail experiment a: fragments 63, 267, and 291 in complex with endothiapepsin

5MB0: “Cocktail experiment a: fragments 63, 267, and 291 in complex with endothiapepsin”. X-ray diffraction, 3 ligands (F91, 47V, F63), 1 pocket (best druggability 0.57). MolNFT v1 #126711 on GenesisL1: 3D structure, binding sites and…

PDB
5MB0
Type
protein
Length
330 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endothiapepsin
EC
3.4.23.22
UniProt
P11838
Ligands
F91, 47V, F63
Pockets
1 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 12% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEndothiapepsin (EC 3.4.23.22)protein33012% helix, 45% strandP11838

Ligands and binding sites

  • F91 · N-(pyridin-4-ylmethyl)-2,3-dihydro-1,4-benzodioxin-6-amine · ligand · 2 copies · chains A
  • 47V · 2,5-dimethyl-N-(pyridin-4-yl)furan-3-carboxamide · ligand · chains A
  • F63 · N-methyl-1-[5-(pyridin-3-yloxy)furan-2-yl]methanamine · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 6 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13110.570.763847V, F91, F63

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5MB0 · Cocktail experiment A: fragments 63, 267, and 291 in complex with Endothiapepsin · the same entry in another collection · chain A against A, TM-score 1.00
  • P11838 · AlphaFold monomer V2.0 prediction for endothiapepsin (P11838) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.